HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideya Onishi Selected Research

Alkaline Phosphatase

2/2016Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideya Onishi Research Topics

Disease

59Neoplasms (Cancer)
02/2024 - 12/2002
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 12/2009
11Hypoxia (Hypoxemia)
07/2023 - 06/2011
9Carcinoma (Carcinomatosis)
07/2022 - 10/2003
8Adenocarcinoma
08/2021 - 12/2010
8Breast Neoplasms (Breast Cancer)
07/2018 - 11/2003
7Neoplasm Metastasis (Metastasis)
09/2018 - 12/2003
5Inflammation (Inflammations)
11/2023 - 12/2009
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2023 - 11/2017
3Gallbladder Neoplasms (Gallbladder Cancer)
07/2023 - 05/2017
3Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2022 - 03/2013
3Colonic Neoplasms (Colon Cancer)
12/2010 - 12/2009
2Ascites
07/2021 - 02/2016
2Fibrosis (Cirrhosis)
01/2021 - 01/2020
2Cholangiocarcinoma
01/2018 - 06/2012
2Stomach Neoplasms (Stomach Cancer)
10/2017 - 07/2011
2Carcinogenesis
09/2013 - 10/2011
2Hepatocellular Carcinoma (Hepatoma)
04/2013 - 07/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2012 - 12/2003
2Melanoma (Melanoma, Malignant)
11/2011 - 12/2003
2Colorectal Neoplasms (Colorectal Cancer)
07/2011 - 12/2003
2Malignant Pleural Effusion
11/2003 - 05/2002
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2024
1Thymoma (Thymic Carcinoma)
08/2022
1Ovarian Neoplasms (Ovarian Cancer)
07/2021
1Cholelithiasis
09/2018
1Triple Negative Breast Neoplasms
07/2018

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
07/2023 - 12/2003
8AntigensIBA
01/2023 - 05/2002
8GemcitabineFDA Link
01/2021 - 07/2011
7Peptides (Polypeptides)IBA
01/2023 - 07/2011
7Phosphotransferases (Kinase)IBA
08/2022 - 03/2013
7TropomyosinIBA
08/2022 - 03/2013
7Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2022 - 03/2013
7Small Interfering RNA (siRNA)IBA
03/2019 - 07/2011
6VaccinesIBA
07/2022 - 12/2003
5CytokinesIBA
05/2022 - 07/2011
5LigandsIBA
08/2014 - 06/2011
5Interleukin-4 (Interleukin 4)IBA
06/2012 - 04/2004
4Interleukin-12 (IL 12)IBA
06/2013 - 12/2002
4cyclopamineIBA
06/2013 - 12/2011
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2012 - 04/2004
3Immune Checkpoint InhibitorsIBA
02/2024 - 10/2019
3InterferonsIBA
11/2023 - 07/2011
3Biomarkers (Surrogate Marker)IBA
01/2023 - 07/2019
3Neoplasm Antigens (Tumor Antigens)IBA
07/2022 - 12/2002
3Carrier Proteins (Binding Protein)IBA
08/2018 - 02/2016
3Immunoglobulins (Immunoglobulin)IBA
08/2018 - 02/2016
3Epithelial Cell Adhesion MoleculeIBA
07/2018 - 08/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2017 - 06/2010
3Matrix Metalloproteinases (MMPs)IBA
08/2016 - 09/2013
3NF-kappa B (NF-kB)IBA
05/2010 - 12/2004
2Immune Checkpoint ProteinsIBA
02/2024 - 11/2023
2Protein Tyrosine PhosphatasesIBA
02/2024 - 11/2023
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2023 - 12/2004
2EpitopesIBA
08/2021 - 07/2021
2Leukocyte Common Antigens (CD45 Antigen)IBA
03/2019 - 12/2017
2catumaxomabIBA
07/2018 - 08/2014
2Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 07/2011
2Cisplatin (Platino)FDA LinkGeneric
01/2017 - 11/2012
2Messenger RNA (mRNA)IBA
08/2014 - 06/2010
2micaIBA
08/2014 - 07/2011
2Oxygen (Dioxygen)IBA
06/2013 - 06/2011
2Monoclonal AntibodiesIBA
06/2012 - 11/2003
2matrigelIBA
02/2011 - 12/2009
2Transforming Growth Factor beta (TGF-beta)IBA
05/2010 - 10/2003
2PicibanilIBA
11/2003 - 09/2003
1Therapeutic UsesIBA
02/2024
1RNA (Ribonucleic Acid)IBA
11/2023
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2023
1Granzymes (Granzyme)IBA
11/2023
1Histocompatibility Antigens Class IIIBA
01/2023
1Formaldehyde (Formol)FDA Link
08/2022
1ParaffinIBA
08/2022
1NivolumabIBA
07/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022
1AminopeptidasesIBA
01/2022
1Fibronectins (Fibronectin)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1TrypsinIBA
08/2021
1Cancer VaccinesIBA
08/2021
1A-factor (Streptomyces)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
07/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1ONO-7579IBA
01/2018
1Metronidazole (Metric)FDA LinkGeneric
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017
1Vascular Endothelial Growth Factor CIBA
05/2017
1Vascular Endothelial Growth Factor DIBA
05/2017
1Neutralizing AntibodiesIBA
12/2016
1polysaccharide-KIBA
08/2016
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2016
1DNA (Deoxyribonucleic Acid)IBA
02/2016

Therapy/Procedure

23Immunotherapy
02/2024 - 12/2002
19Therapeutics
02/2024 - 11/2003
10Drug Therapy (Chemotherapy)
01/2020 - 11/2003
2Gastrectomy
10/2017 - 01/2016
2Intravenous Injections
11/2005 - 11/2003
1Oral Administration
11/2023
1Cholecystectomy
09/2018